Janel Holsten is an experienced clinical research professional with a diverse background in clinical trial management and monitoring. Currently serving as the Director of Clinical Monitoring at Inhibrx, Inc. since April 2022, Janel has previously held key positions at various organizations, including Senior Clinical Trial Manager at ICON plc and Clinical Trial Manager at Worldwide Clinical Trials Early Phase Services. Janel's career includes roles with IQVIA, PRA Health Sciences, and other notable clinical research firms, demonstrating a strong progression in responsibilities from Clinical Scientist at Restoragen to leadership and specialized roles. Janel holds a BS in Biology and Chemistry from Nebraska Wesleyan University and has earned a Clinical Research Associate certification from SoCRA.
This person is not in the org chart
This person is not in any teams
This person is not in any offices